Stock Update (NYSE:BAX): Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation

[Business Wire] – Baxter Ventures, the venture arm of Baxter International Inc. , the Mayo Clinic and Velocity Pharmaceutical Development, LLC today announced the formation of Vitesse Biologics, LLC, . Read more on . . . → Read More: Stock Update (NYSE:BAX): Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation Similar Articles: Market Update (NYSE:BAX): Baxter and Baxalta Highlight Business Strategies at Investor Conferences Company Update: Baxter International Inc (NYSE:BAX) – Baxter to Webcast Annual Meeting of Shareholders Market Update (NYSE:BAX): Baxter’s BioScience Business Acquires Biopharmaceutical Company SuppreMol